MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹477 Cr | ₹390 Cr | ₹341 Cr | ₹380 Cr | ₹299 Cr |
What is the latest Total Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹477 Cr |
| Mar2024 | ₹390 Cr |
| Mar2023 | ₹341 Cr |
| Mar2022 | ₹380 Cr |
| Mar2021 | ₹299 Cr |
How is Total Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹477 Cr | 22.44 | |
| Mar2024 | ₹390 Cr | 14.33 | |
| Mar2023 | ₹341 Cr | -10.29 | |
| Mar2022 | ₹380 Cr | 27.13 | |
| Mar2021 | ₹299 Cr | - | |
Compare Total Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,107.7 Cr | -2.2% | -6.5% | -38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -2.2% |
-6.5% |
-38% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses